Canaccord Genuity Maintains Buy Rating on Concentrix
Canaccord Genuity reiterated its buy rating on Concentrix, setting a $45 price target, a 100.85% upside from the current price.
Key Points
- Canaccord Genuity reiterated its buy rating on Concentrix Corporation (CNXC) with a price target of $45 on June 30, 2026.
- Canaccord Genuity's $45 price target implies 100.85% upside from Concentrix Corporation's ($CNXC) current $22.41 share price.
- Shares of Concentrix traded near $25.23 on Tuesday, with a market cap of about $1.53 billion and a forward P/E ratio of 1.95.
- Insiders and institutional investors have been active in Concentrix, with insiders buying shares and funds like AQR Capital Management increasing their holdings.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Canaccord Genuity has reiterated its buy rating on Concentrix Corporation (NasdaqGS:CNXC), setting a price target of $45. Analyst Luke Morison made the announcement on June 30, 2026. This maintains the firm's positive outlook on the technology services company.
Canaccord Genuity vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in Concentrix
Several institutional investors have been active in Concentrix. AQR Capital Management LLC increased its stake by 1,881,581 shares, ending with 4,831,868 shares valued at approximately $132.2 million. FMR LLC also boosted its holdings by 1,414,243 shares, bringing its total to 4,223,282 shares worth about $115.5 million. BlackRock, Inc. added 235,325 shares, taking its total to 4,062,197 shares valued at $111.1 million. Dimensional Fund Advisors LP lifted its position by 460,108 shares, totaling 2,951,378 shares worth around $80.7 million.
Concentrix Corporation Stock Down 23.7%
Shares of Concentrix Corporation traded near $25.23 on Tuesday. The company has a market cap of approximately $1.53 billion and a forward P/E ratio of 1.95. Its beta stands at 0.423, indicating lower volatility compared to the broader market. The stock's 52-week range is between $22.05 and $62.14, with a 50-day moving average of $25.86 and a 200-day moving average of $35.66. Concentrix's current ratio is 1.181, and its quick ratio is 0.878, with a debt-to-equity ratio of 204.038.
$CNXC price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
Concentrix reported revenue of $9.95 billion with a growth rate of 5.4%. Despite the revenue growth, the company posted a net margin of -13.34% and a return on equity of -38.92%. The next earnings report is scheduled for June 29, 2026.
Dividend
Concentrix offers an annual dividend rate of $1.44, yielding 5.76%. The dividend payout ratio is 28.2%, indicating a conservative approach to dividend distribution.
Insider Buying and Selling at Concentrix Corporation
Insider activity at Concentrix includes several transactions. On April 29, 2026, Groupe Bruxelles Lambert sold 6,000,000 shares at $22.25 each. On April 9, 2026, Valentine Andre, the CFO, purchased 2,500 shares at $27.95. President and CEO Christopher Caldwell bought 1,000 shares at $26.97 on March 26, 2026. Other insiders, including Laverne Council, Jennifer Deason, and Kathryn Hayley, each acquired 7,701 shares on March 25, 2026, at no cost.
Analysts Set New Price Targets
On June 30, 2026, Canaccord Genuity maintained its buy rating on Concentrix with a $45 target. Barrington Research and Baird also maintained buy ratings, setting targets of $30 each. The consensus among four analysts is a buy recommendation, with a mean price target of $41.25.
About Concentrix
Concentrix Corporation, based in Newark, California, specializes in customer experience solutions. It offers services like CX process optimization, technology innovation, and digital transformation to industries such as technology, retail, and healthcare. Founded in 2004, the company operates globally under the leadership of CEO Christopher A. Caldwell and employs about 455,000 people.
Bottom Line
Canaccord Genuity's reaffirmation of its buy rating on Concentrix highlights ongoing confidence in the company's potential. With active institutional interest and insider transactions, Concentrix remains a closely watched player in the technology services sector. Remember, 13F filings and analyst ratings reflect past positions and opinions, not current recommendations.
Get Concentrix Corporation alerts
New 13F filings, insider trades, and analyst moves on $CNXC, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.